Mingfa Group (00846): The remaining two subsidiary companies in China have submitted applications for changes in their directors to the local regulatory authorities and are waiting for approval.
Mingfa Group (00846) has issued an announcement regarding the proposed restructuring of its subsidiary companies in China. The respective boards of directors of the companies have made recommendations on the matter, and a meeting will be held on... for further discussion.
MINGFA GROUP (00846) announced that the respective boards of directors of its Chinese subsidiaries have proposed a restructuring. As of the date of this announcement, the remaining two Chinese subsidiaries have submitted applications for changes in their directors to the local regulatory authorities and are awaiting approval. The proposed restructuring at the subsidiary level will be completed after the relevant approvals are obtained from the local authorities.
Related Articles

JS GLOBAL LIFE (01691): Huang Shuling resigns as executive director

JS Global Life (01691): Executive Director Han Run appointed as Chief Executive Officer.

ZHONGZHIPHARM (03737) announced that the profit attributable to equity holders in 2025 was RMB 17.29 million, a year-on-year decrease of 81.8%.
JS GLOBAL LIFE (01691): Huang Shuling resigns as executive director

JS Global Life (01691): Executive Director Han Run appointed as Chief Executive Officer.

ZHONGZHIPHARM (03737) announced that the profit attributable to equity holders in 2025 was RMB 17.29 million, a year-on-year decrease of 81.8%.

RECOMMEND

Chinese Innovative Drug Assets Attract Major Foreign Acquisition, Cooperation Models Diversify
26/03/2026

Four Giants Subscribe As Memory Manufacturer Confirms TWD 78.718 Billion Private Placement For Capacity Expansion
26/03/2026

Year‑On‑Year Surge Exceeding 500%: Hong Kong IPOs Top HKD 100 Billion This Year
26/03/2026


